Fusion Pharmaceuticals Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $973K, a 123% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $6.59M, a 350% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $1.47M, a 27.9% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $973K +$536K +123% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $437K +$76K +21.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $361K +$81K +28.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $280K Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.